Portolan Capital Management’s Maravai LifeSciences MRVI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,792,529
Closed -$14.9M 152
2024
Q3
$14.9M Sell
1,792,529
-53,611
-3% -$446K 1.08% 26
2024
Q2
$13.2M Buy
1,846,140
+1,165,684
+171% +$8.35M 1.09% 26
2024
Q1
$5.9M Buy
+680,456
New +$5.9M 0.45% 78